共 50 条
- [1] Selective Support of CAR-T Cell Therapies By Cis-Targeted IL-2 or IL-21 Cytokines Results in Enhanced Anti-Tumor Activity[J]. BLOOD, 2022, 140 : 10259 - 10260Sleiman, Sara论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USAMathewson, Nathan D.论文数: 0 引用数: 0 h-index: 0机构: Asher Biotherapeut, San Francisco, CA USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USAShen, Feng论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USAMoynihan, Kelly论文数: 0 引用数: 0 h-index: 0机构: Asher Biotherapeut, San Francisco, CA USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USAChen, Wei论文数: 0 引用数: 0 h-index: 0机构: Asher Biotherapeut, San Francisco, CA USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USABessette, Paul论文数: 0 引用数: 0 h-index: 0机构: Asher Biotherapeut, San Francisco, CA USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USAKimberlin, Chris论文数: 0 引用数: 0 h-index: 0机构: Asher Biotherapeut, San Francisco, CA USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USAPappas, Danielle论文数: 0 引用数: 0 h-index: 0机构: Asher Biotherapeut, San Francisco, CA USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USAPark, Terrence论文数: 0 引用数: 0 h-index: 0机构: Asher Biotherapeut, San Francisco, CA USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USAYeung, Andy论文数: 0 引用数: 0 h-index: 0机构: Asher Biotherapeut, San Francisco, CA USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USADjuretic, Ivana论文数: 0 引用数: 0 h-index: 0机构: Asher Biotherapeut, San Francisco, CA USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USAGill, Saar论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA Univ Penn, Div Hematol Oncol, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA Univ Penn, Abramson Canc Ctr, Cellular Therapy & Transplantat, Philadelphia, PA 19104 USA Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA
- [2] ROLE OF CAR EXPRESSION LEVELS IN THE ANTI-TUMOR EFFICACY OF CAR-T CELLS[J]. HAEMATOLOGICA, 2021, 106 (10) : 58 - 59Rodriguez-Marquez, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainCalleja-Cervantes, M. E.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainSerrano, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Biol Computac, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainSan Martin-Uriz, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainVilas-Zornoza, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainMartin-Mallo, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainRodriguez-Diaz, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainMartinez-Turrillas, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainJauregui, P.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, Area Terapia Celular, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainCalvino, C.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, Area Terapia Celular, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainInoges, S.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, Area Terapia Celular, IdiSNA, Navarra, Spain Clin Univ Navarra, Dept Inmunol & Inmunoterapia, Navarra, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainLopez-Diaz, de Cerio A.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, Area Terapia Celular, IdiSNA, Navarra, Spain Clin Univ Navarra, Dept Inmunol & Inmunoterapia, Navarra, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainPalacios-Berraquero, M. L.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, Dept Hematol & Hemoterapia, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainRodriguez-Otero, P.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, Dept Hematol & Hemoterapia, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainRifon, J.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, Area Terapia Celular, IdiSNA, Navarra, Spain Clin Univ Navarra, Dept Hematol & Hemoterapia, IdiSNA, Navarra, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainAlfonso, A.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, Dept Hematol & Hemoterapia, IdiSNA, Navarra, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainLasarte, J. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Inmunol & Inmunoterapia, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainLozano, T.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Inmunol & Inmunoterapia, IdiSNA, Navarra, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainHernaez, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Biol Computac, IdiSNA, Navarra, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainRodriguez-Madoz, J. R.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, SpainProsper, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, Spain Clin Univ Navarra, Area Terapia Celular, IdiSNA, Navarra, Spain Clin Univ Navarra, Dept Hematol & Hemoterapia, IdiSNA, Navarra, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Univ Navarra, CIMA, Programa Hematooncol, IdiSNA, Navarra, Spain
- [3] IL-2 VARIANT IMPROVES CAR-T FUNCTIONALITY AND EFFICACY AGAINST SOLID TUMORS[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A120 - A120Dong, Qi论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaYin, Wenjie论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaJiang, Pengfei论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaYin, Manli论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaWang, Tao论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaWang, Ping论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaWang, Xinxin论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaCao, William Wei论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaShen, Lianjun论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R China
- [4] Engineered cell surface tag-targeted IL-2 and IL-21 selectively and safely enhance CAR-T anti-tumor activity via different mechanisms[J]. CANCER RESEARCH, 2023, 83 (07)Mathewson, Nathan D.论文数: 0 引用数: 0 h-index: 0Chen, Wei论文数: 0 引用数: 0 h-index: 0Bessette, Paul论文数: 0 引用数: 0 h-index: 0Sleiman, Sara论文数: 0 引用数: 0 h-index: 0Sukthankar, Meghana论文数: 0 引用数: 0 h-index: 0Moynihan, Kelly D.论文数: 0 引用数: 0 h-index: 0Kimberlin, Chris论文数: 0 引用数: 0 h-index: 0Park, Terrence论文数: 0 引用数: 0 h-index: 0Hollingsworth, Audrey论文数: 0 引用数: 0 h-index: 0Gill, Saar论文数: 0 引用数: 0 h-index: 0Yeung, Andy论文数: 0 引用数: 0 h-index: 0Djuretic, Ivana论文数: 0 引用数: 0 h-index: 0
- [5] Development of CAR-T Cell Constructs with Broad Anti-Tumor Tropism[J]. BLOOD, 2020, 136Mishra, Ameet K.论文数: 0 引用数: 0 h-index: 0Kemler, Iris论文数: 0 引用数: 0 h-index: 0Dingli, David论文数: 0 引用数: 0 h-index: 0
- [6] Preface of the Special Issue "Anti-Tumor CAR-T Cell Therapy"[J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2021, 41 (01) : V - VIPassos, Geraldo Aleixo论文数: 0 引用数: 0 h-index: 0机构: Univ Sao Paulo, Ribeirao Preto Campus, Ribeirao Preto, SP, Brazil Univ Sao Paulo, Ribeirao Preto Campus, Ribeirao Preto, SP, Brazil
- [7] Optimizing CAR-T cell Culture: Differential effects of IL-2, IL-12, and IL-21 on CAR-T cells[J]. CYTOKINE, 2024, 184Zhang, Mengmeng论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Dept Hematol, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaKong, Jingjing论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Dept Hematol, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaYin, Fanxiang论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaShi, Jianxiang论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Inst Med & Pharmaceut Sci, Precis Med Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaLi, Jin论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Dept Hematol, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaQiu, Zan论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Inst Med & Pharmaceut Sci, Precis Med Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaYue, Baohong论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Dept Lab Med, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaWang, Shuya论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Dept Blood Transfus, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaSun, Nannan论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Dept Hematol, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaLin, Quande论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaFu, Liyan论文数: 0 引用数: 0 h-index: 0机构: Henan Univ Chinese Med, Affiliated Hosp 1, Dept Lab Med, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaWang, Xiaoqian论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Dept Lab Med, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaSun, Xianlei论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Acad Med Sci, Basic Med Res Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaGao, Yanxia论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Dept Emergency Med, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaJiang, Yong论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Dept Emergency Med, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Henan Key Lab Crit Care Med, Dept Crit Care Med, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R ChinaGuo, Rongqun论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Dept Hematol, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou, Henan, Peoples R China
- [8] Armed with IL-2 based fusion protein improves CAR-T cell fitness and efficacy against solid tumors[J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (05):Li, Sijin论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R China Xuzhou Med Univ, Ctr Clin Oncol, Affiliated Hosp, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R ChinaXia, Yifei论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R China Xuzhou Med Univ, Ctr Clin Oncol, Affiliated Hosp, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R ChinaHou, Rui论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Coll Pharm, Xuzhou, Jiangsu, Peoples R China Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R ChinaWang, Xu论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R China Xuzhou Med Univ, Ctr Clin Oncol, Affiliated Hosp, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R ChinaZhao, Xuan论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R China Xuzhou Med Univ, Ctr Clin Oncol, Affiliated Hosp, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R ChinaGuan, Zhangchun论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R China Xuzhou Med Univ, Ctr Clin Oncol, Affiliated Hosp, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R ChinaMa, Wen论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R China Xuzhou Med Univ, Ctr Clin Oncol, Affiliated Hosp, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R China论文数: 引用数: h-index:机构:Liu, Dan论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R China Xuzhou Med Univ, Ctr Clin Oncol, Affiliated Hosp, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R China论文数: 引用数: h-index:机构:Shi, Ming论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R China Xuzhou Med Univ, Ctr Clin Oncol, Affiliated Hosp, Xuzhou, Peoples R China Xuzhou Med Univ, Canc Inst, Xuzhou, Peoples R China
- [9] A combination of CAR-NK and CAR-T cells results in rapid and persistent anti-tumor efficacy while reducing CAR-T cell mediated cytokine release and T-cell proliferation[J]. CANCER RESEARCH, 2020, 80 (16)Li, Guangnan论文数: 0 引用数: 0 h-index: 0机构: Nkarta Therapeut, San Francisco, CA USA Nkarta Therapeut, San Francisco, CA USAWu, Xiumin论文数: 0 引用数: 0 h-index: 0机构: Nkarta Therapeut, San Francisco, CA USA Nkarta Therapeut, San Francisco, CA USAChan, Ivan H.论文数: 0 引用数: 0 h-index: 0机构: Nkarta Therapeut, San Francisco, CA USA Nkarta Therapeut, San Francisco, CA USATrager, James B.论文数: 0 引用数: 0 h-index: 0机构: Nkarta Therapeut, San Francisco, CA USA Nkarta Therapeut, San Francisco, CA USA
- [10] IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells[J]. BRITISH JOURNAL OF CANCER, 2024, 130 (08) : 1337 - 1347Zhang, Kai论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R ChinaHu, Wenhao论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R China论文数: 引用数: h-index:机构:Wen, Chunli论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R ChinaZhou, Lingxiao论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R ChinaZhang, Lei论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R ChinaLian, Jingyao论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R ChinaLiu, Shasha论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R ChinaWang, Shumin论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R ChinaZhang, Yi论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R China State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Sch Life Sci, Zhengzhou, Henan, Peoples R China Henan Key Lab Tumor Immunol & Biotherapy, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr & Canc Ctr, Zhengzhou, Henan, Peoples R China